3063 POSTER Capecitabine (C), in combination with irinotecan (I) and oxaliplatin (O) (XELOXIRI) as first-line treatment of metastatic colorectal cancer (MCRC): results of a pilot study by the Gruppo Oncologico Nord-Ovest (G.O.N.O.)
S. Bursi, G. Masi, F. Loupakis, A. Antonuzzo, S. Chiara, E. Pfanner, I. Petrini, M.T. Barletta, G.G. Baldi, A. FalconeVolume:
5
Year:
2007
Language:
english
DOI:
10.1016/s1359-6349(07)70991-6
File:
PDF, 57 KB
english, 2007